Aug 15, 2018 10:20 am EDT BioRestorative Therapies Announces Publication of Study Results Validating the Benefits of Using Hypoxic Cultured Cells to Treat Patients with Degenerative Disc Disease
Jul 25, 2018 9:45 am EDT BioRestorative Therapies Appoints Jason M. Lipetz, M.D. to its Scientific Advisory Board
Jun 11, 2018 9:45 am EDT BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program
May 7, 2018 9:45 am EDT BioRestorative Therapies Appoints Wayne J. Olan, M.D. as Clinical Director of Regenerative Disc/Spine Program
Jan 22, 2018 11:00 am EST BioRestorative Therapies Announces the Appointment of Adam D. Bergstein as Sr. VP, Planning and Business Development
Oct 17, 2017 9:45 am EDT BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in Japan
Oct 5, 2017 9:45 am EDT BioRestorative Therapies Announces Published Study of Licensed Technology to Treat Lumbar Degenerative Disc Disease
Jun 14, 2017 9:45 am EDT BioRestorative Therapies to Present at 6th Annual Marcum MicroCap Conference
Apr 20, 2017 9:45 am EDT BioRestorative Therapies Receives Notice of Acceptance for Key Metabolic Patent in Australia
Feb 8, 2017 9:45 am EST BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease